As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Elucidata builds Polly, a platform that cleans, harmonises and annotates biomedical data so that machine learning models can use it. Founded in 2016 by IIT graduates with offices in Cambridge and Delhi, it addresses the fact that most life science data is not analysis-ready. Its customers include large pharmaceutical companies and biotech startups.
News
Why single-cell foundation models have underdelivered and what drug discovery needs instead
Foundation models have delivered breakthroughs in protein biology, but single-cell models have struggled to match them. What is holding them back?
Read more
Report
FAIR Data Infrastructure in Life Sciences R&D
Navigating the complexities and challenges in preclinical drug discovery (Part 1 of 3)
Read more
Report
AI for DD Landscape: Focus on Asia Deep Pharma Intelligence
This "World's AI for Drug Development Landscape: Focus on Asia" report represents the eleventh issue of market analytics focused on the Artificial Intelligence (AI) application in the pharmaceutical research industry and especially in Asia region.
Read more
Report
Doing More with Moore: Biotech's Tech Moment
The biotech industry's appetite for science-native SaaS tools is accelerating and will modernize how medicines are discovered, developed, and distributed.
Read more
Report
Extreme Tech Startup Spotlight: Elucidata
This week in our Startup Spotlight blog series is our 2020 XTC Healthcare Finalist - Elucidata
Read more
Report
Pro access
Upgrade to see all 17 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
